Top section
Top section
Helios's Moroccan health tech company T2S lists in Casablanca
Frédéric Despagne will also lead equity and derivatives sales across EMEA
Steel processor allocates fifth of $94.68m initial offering to foreign institutional investors
More articles
More articles
More articles
-
Chinese question-and-answer platform Zhihu has raised $522.5m from its US IPO, after pricing the deal at the bottom of the marketed range, according to a source familiar with the matter. -
Chinese firm Linklogis has thrown open the book for its Hong Kong IPO, aiming to pocket up to HK$8.28bn ($1.06bn).
-
Last year GlobalCapital was forced to abandon our 2019 Equity Capital Markets Awards dinner because of the Covid-19 pandemic. Little did we know that what seemed like a brief crisis would transform all our lives in the way it has. But despite the huge pressure of the virus and its dramatic impact on stockmarkets, the equity capital markets rose to the challenge in 2020, enabling many companies to raise vital capital to mend broken balance sheets and even to complete IPOs, all without executives having to leaving their home countries — or even their homes. After an extraordinary year, GlobalCapital is pleased to recognise the truly outstanding achievements in ECM.
-
The polite world of sustainable finance has collided with the ugly reality of politics in the past week, as open strife has broken out over the European Union’s sustainable finance legislation, especially the Taxonomy. Conservative and progressive elements are battling over a host of issues, above all whether gas power should ever be classed as sustainable, and the validity and even legality of the Taxonomy is being called into question.
-
Equity investors and bankers are increasingly fearful that the European IPO market is running far too hot, with over-cooked valuations blowing an asset bubble. Investors are already overworked and have little time to give the bulging pipeline of up to 100 more IPOs the proper scrutiny they need, reports Sam Kerr.
-
Siemens Healthineers, the German healthcare tech company, has completed the second leg of equity financing to fund its acquisition of US cancer care solutions firm Varian. The involvement of a large anchor investor was revealed at the top of the book, which was quickly filled with long-only investors.
Sub-sections
shared comment list
